These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8218756)

  • 21. Single dose treatment with H2 receptor antagonists: is bedtime administration too late?
    Merki H; Witzel L; Harre K; Scheurle E; Neumann J; Röhmel J
    Gut; 1987 Apr; 28(4):451-4. PubMed ID: 3583073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration.
    Gardner JD; Ciociola AA; Robinson M
    J Appl Physiol (1985); 2002 Feb; 92(2):427-34. PubMed ID: 11796648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
    Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
    Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.
    Robert A; Kane G; Reele SB
    Gut; 1981 Sep; 22(9):728-31. PubMed ID: 7297921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma pharmacokinetics of ranitidine HCl in foals.
    Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
    J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of food on ranitidine-induced inhibition of nocturnal gastric secretion.
    Johnston DA; Wormsley KG
    Aliment Pharmacol Ther; 1988 Dec; 2(6):507-11. PubMed ID: 2979273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine.
    Williams MF; Dukes GE; Heizer W; Han YH; Hermann DJ; Lampkin T; Hak LJ
    Pharm Res; 1992 Sep; 9(9):1190-4. PubMed ID: 1409403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The timing of evening meal and ranitidine administration--effects on patterns of 24 hour intragastric acidity.
    Orr WC; Finn AL; Allen M; Robinson MG; Wilson T
    Aliment Pharmacol Ther; 1988 Dec; 2(6):541-9. PubMed ID: 2979277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the safety of ranitidine during seven years daily oral administration to beagle dogs.
    Spurling NW; Selway SA; Poynter D
    Hum Toxicol; 1989 Jan; 8(1):23-32. PubMed ID: 2714806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oral ranitidine in Mexicans.
    Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V; Herrera-Abarca A; Pérez-Urizar J; Herrera JE; Hong E
    Arch Med Res; 1996; 27(3):349-52. PubMed ID: 8854394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of 300 mg ranitidine at night, twice daily and four times daily on intragastric acidity in normal subjects.
    Primrose JN; Rogers MJ; Holmfield JH
    Aliment Pharmacol Ther; 1993 Jun; 7(3):287-91. PubMed ID: 8364134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged influence of a meal on the effect of ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1984 May; 19(3):429-32. PubMed ID: 6330872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged inhibition of meal-stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201-995) in man.
    Karnes WE; Maxwell V; Sytnik B; Chew P; Walsh JH
    Aliment Pharmacol Ther; 1989 Dec; 3(6):527-38. PubMed ID: 2518866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.